Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Reduced price
Risk Assessment and Management in Cancer Genetics

Risk Assessment and Management in Cancer Genetics

9780198529606
807.30 zł
726.57 zł Save 80.73 zł Tax included
Lowest price within 30 days before promotion: 726.57 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
The need to expand expertise in cancer genetics beyond highly specialized genetics clinics is increasingly being recognized. In response, this practical book provides oncologists, specialist nurses, genetic counsellors, family doctors, and geneticists with comprehensive and easy-to-use guidelines on risk assessment and appropriate management.The book focuses on common familial cancers such as breast, colorectal, ovary, prostate and melanoma, and separate chapters cover cancer predisposing syndromes such as neurofibromatosis, familial adenomatous polyposis and their management.
Product Details
OUP Oxford
84275
9780198529606
9780198529606

Data sheet

Publication date
2005
Issue number
1
Cover
paperback
Pages count
288
Dimensions (mm)
168 x 240
Weight (g)
495
  • Introduction; How to evaluate a family history; Guidelines for referral in Europe; Guidelines for genetic counselling, testing and referral in North America; Principles and applications of gene testing for common cancers; Risk assessment of common malignancies; Risk estimation in breast cancer; Risk estimation in colorectal cancer; Risk estimation in ovarian cancer; Management of familial breast and ovarian cancer in Europe; Management of familial breast and ovarian cancer in North America; Management of familial adenomatous polyposis and other inherited polyposis syndromes; Management of hereditary non-polyposis colorectal cancer; Management and risk assessment of less common familial cancers; Inherited cancer syndromes; The neurofibromatoses; von Hippel-Lindau disease; Multiple endocrine neoplasias; Gorlin Syndrome; The Li-Frameni Syndrome; Other tumour predisposing syndromes; The ethical and insurance issues of cancer genetics;
Comments (0)
Viewed products

  • Frequently purchased together

    No products available